Rare diseases
Investigational molecules
Locations
A study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FrancePhase 2 Study Evaluating Safety and Efficacy of Belzutifan in Adults with Solid Tumors
BelgiumPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
AustriaA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
CzechiaLaroprovstat/rosuvastatin versus rosuvastatin for lowering LDL‑C in patients with high cholesterol
GermanyA Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
FranceNon‑inferiority of fractional varicella zoster virus glycoprotein E vaccine (AS01B) versus recombinant varicella zoster virus glycoprotein E vaccine in adults with shingles
The NetherlandsLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
BelgiumStudy of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years
BelgiumEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
BelgiumAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
FrancePhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
